Ketoconazole: Difference between revisions
No edit summary |
|||
| Line 6: | Line 6: | ||
==Adult Dosing== | ==Adult Dosing== | ||
===Fungal infections=== | |||
*200-400 mg PO qday | |||
===Prostate cancer=== | |||
*400 mg PO q8h | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
===Fungal infectionss (2 years and up)=== | |||
*3.3-6.6 mg/kg PO qday | |||
==Special Populations== | ==Special Populations== | ||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C | *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C | ||
*[[Lactation risk categories|Lactation risk]]: Safety Unknown | *[[Lactation risk categories|Lactation risk]]: Safety Unknown | ||
===Renal Dosing=== | ===Renal Dosing=== | ||
*Adult: no adjustment | *Adult: no adjustment | ||
| Line 31: | Line 33: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*Hepatotoxicity | *[[Hepatotoxicity]] | ||
*Adrenal insufficiency | *[[Adrenal insufficiency]] | ||
*Hypersensitivity reaction | *[[Hypersensitivity reaction]] | ||
*Anaphylaxis | *[[Anaphylaxis]] | ||
*Thrombocytopenia | *[[Thrombocytopenia]] | ||
*Leukopenia | *[[Leukopenia]] | ||
*Hemolytic | *[[Hemolytic anemia]] | ||
===Common=== | ===Common=== | ||
*Nausea | *[[Nausea]] | ||
*Abdominal | *[[Abdominal pain]] | ||
*Dizziness | *[[Dizziness]] | ||
*Diarrhea | *[[Diarrhea]] | ||
*Headache | *[[Headache]] | ||
*Pruritis | *[[Pruritis]] | ||
*Lethargy | *[[Lethargy]] | ||
*Gynecomastia | *[[Gynecomastia]] | ||
==Pharmacology== | ==Pharmacology== | ||
Revision as of 06:18, 17 September 2015
Administration
- Type: Antifungal [1]
- Dosage Forms:
- Routes of Administration: PO, topical
- Common Trade Names:
Adult Dosing
Fungal infections
- 200-400 mg PO qday
Prostate cancer
- 400 mg PO q8h
Pediatric Dosing
Fungal infectionss (2 years and up)
- 3.3-6.6 mg/kg PO qday
Special Populations
- Pregnancy Rating: C
- Lactation risk: Safety Unknown
Renal Dosing
- Adult: no adjustment
- Pediatric: no adjustment
Hepatic Dosing
- Adult: contraindicated in liver disease
- Pediatric: contraindicated in liver disease
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Hepatotoxicity
- Adrenal insufficiency
- Hypersensitivity reaction
- Anaphylaxis
- Thrombocytopenia
- Leukopenia
- Hemolytic anemia
Common
Pharmacology
- Half-life: 8 h
- Metabolism: Liver (CYP450)
- Excretion: feces > urine
Mechanism of Action
- Inhibits synthesis of cell membrane ergosterol
Comments
See Also
References
- ↑ Epocrates, 2015.